Vitiligo after Diphencyprone for Alopecia Areata
Joint Authors
Martins, João Mauricio
Gatti, Flávia Romero
Pires, Mario Cezar
Montealegre, F.
Source
Dermatology Research and Practice
Issue
Vol. 2010, Issue 2010 (31 Dec. 2010), pp.1-2, 2 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2010-05-11
Country of Publication
Egypt
No. of Pages
2
Main Subjects
Abstract EN
The topical immunotherapy is used to treat alopecia areata and recalcitrant warts since the 1970s.
Diphencyprone is a contact sensitizer used to treat dermatological conditions resulting from as altered immunological state, such as extensive alopecia areata, being partially effective and safe.
Side effects include local eczema with blistering, regional lymphadenopathy and contact urticaria.
Rare adverse effects include an erythema multiforme-like reaction, hyperpigmenttion, hypopigmentation, and vitiligo.
We report a 30-year-old, Brazilian male who developed vitiligo lesions following DPCP therapy for alopecia areata.
American Psychological Association (APA)
Pires, Mario Cezar& Martins, João Mauricio& Montealegre, F.& Gatti, Flávia Romero. 2010. Vitiligo after Diphencyprone for Alopecia Areata. Dermatology Research and Practice،Vol. 2010, no. 2010, pp.1-2.
https://search.emarefa.net/detail/BIM-451554
Modern Language Association (MLA)
Pires, Mario Cezar…[et al.]. Vitiligo after Diphencyprone for Alopecia Areata. Dermatology Research and Practice No. 2010 (2010), pp.1-2.
https://search.emarefa.net/detail/BIM-451554
American Medical Association (AMA)
Pires, Mario Cezar& Martins, João Mauricio& Montealegre, F.& Gatti, Flávia Romero. Vitiligo after Diphencyprone for Alopecia Areata. Dermatology Research and Practice. 2010. Vol. 2010, no. 2010, pp.1-2.
https://search.emarefa.net/detail/BIM-451554
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-451554
